Summary
In nonpretreated patients with tumor stage ‘limited disease,’ a combination of chemotherapy and radiotherapy leads to remission rates of 70%–95%. The mean survival time of patients is 12 months, in complete remissions 15–20 months. However, after 2 years, only 5%–10% of patients are free of relapse. In stage IV (metastatic disease) of non-small-cell lung cancer (NSCLC), chemotherapy is only palliative, with remission rates between 25%–45%. In stage III,new results with remission rates between 50%–70% suggest treatment with preoperative induction chemotherapy or new attempts with adjuvant chemotherapy, respectively.
Zusammenfassung
Im Stadium limited disease werden bei nicht-vorbehandelten Patienten durch die Kombination von Chemotherapie und Radiotherapie objektiv meßbare Remissionen in einer Häufigkeit von 70-95% erzielt. Die medianen Überlebensdauern der Patienten betragen 12 Monate, bei kompletten Remissionen 15-20 Monate. Nach 2 Jahren leben jedoch nur noch 5-10% der Patienten rezidivfrei. Bei den nicht-kleinz. Bronchialkarzinomen hat die Chemotherapie im Stadium IV mit Remissionsraten zwischen 25-45% ausschließlich palliativen Charakter. Neue Ergebnisse im Stadium III mit Remissionsraten zwischen 50-70% ergeben Ansätze für eine präoperative Induktionschemoth. bzw. einen erneuten Versuch der adjuvanten Chemotherapie.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bonomi P (1993) Treatment of locally advanced non-small cell lung Cancer. Lung Cancer 9 (Suppl 2): 49–60
Bunn PA, Cullen M, Fukuoka M, Green MR, Hansen HH, Harper P, Johnson D, Klastersky J, Le Chevalier T, Sagman U, Splinter T (1989) Chemotherapy in small cell lung cancer: A consensus report. Lung Cancer 5: 127–134
Comis RL (1993) Extensive small cell lung cancer. Lung Cancer 9 (Suppl 1): 27–39
Donnadieu N, Paesmans M, Sculier JP (1991) Chemotherapy of non small cell lung cancer according to disease extent: A meta-analysis of the literature. Lung Cancer 7: 242–252
Ginsberg RJ (1993) Multimodality therapy for non small cell lung cancer: the role of surgery. Lung Cancer 9 (Suppl 2): 25–30
Green MR (1993) Induction chemotherapy prior to definitive radiation for stage III A and III B non small cell lung cancer. Lung Cancer 9 (Suppl 2): 39–47
Haraf DJ, Devine S, Ihde DC, Vokes EE (1992) The evolving role of systemic therapy in carcinoma of the lung, Sem Oncology 19 (Suppl 1 1): 72–87
Hazuka MB, Bunn PA jun (1992) Controversies in the nonsurgical treatment of stage III non small cell lung cancer. Am Rev Respir Dis 145: 967–977
Johnson DH (1993) Treatment of limited-stage small cell lung cancer: Recent progress and future directions. Lung Cancer 9 (Suppl 1): 1–19
Klastersky J, Sculier JP (1989) Intensive chemotherapy of small cell lung cancer. Lung Cancer 5: 196–296
Postmus PE (1991) Staging and treatment for small cell lung cancer: In: Current Topics in Lung Cancer, Hrsg von Bunn PA, S 47–60, Springer, Berlin Heidelberg New York
Seifter EJ, Ihde DC (1988) Therapy of small cell lung cancer: A perspective on two decades of clinical research. Sem Oncol 15: 279–289
Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA, Kaasa S, Pater JL, Quoix E, Rapp E, Tumarello D, Williams J, Woods BL, Bernard JP (1993) Polychemotherapy in advanced non small cell lung cancer: A meta-analysis Lancet 342: 19–21
Splinter TAW (1989) Chemotherapy of small cell lung cancer: Duration of treatment. Lung Cancer 5: 186–195
Strauss GM, Langer MP, Elias AD, Skarin AT, Sugarbaker DJ (1992) Multimodality treatment of stage IIIA non small cell lung carcinoma: A critical review of the literature and strategies for future research. J Clin Oncol 10: 829–838
Wolf M, Havemann K, Holle R, Gropp C, Drings P, Hans K, Schroeder M, Heinz M, Dommes M, Mende S, Thiel H, Kruska D, Victor N, Georgii A, Braun C (1987) Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small cell lung cancer: A multicenter German randomized trial. J Clin Oncol 5: 1880–1889
Goldstraw P, Mannam GC, Kaplan DK, Michail P (1994) Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N 2 disease). J Thorac Cardiovasc Surg. 107 (1): 19–27
Hata E, Miyamoto H, Tanaka M, Sakao Y, Harada R, Kohiyama R (1994) The necessitiy of extended systemic dissection of the regional lymph node in radical operation for lung cancer. Kyobu Geka 47 (1): 40–44
Kirn DH, Lynch TJ, Metzner SJ, Lee TH, Strauss GM, Elias AD, Skarin AT, Sugarbaker DJ (1993) Multimodality therapy of patients with stage IIIA, N 2 non-small-cell lung cancer. J Thorac Cardiovasc Surg 106 (4): 696–702
Greschuchna D, Maasen W (1973) Die lymphogenen Absiedelungswege des Bronchialkarzinoms. Copythek Thieme Verlag, Stuttgart
Miller DL, MCManus KG, Allen MS et Ilstrup DM, Deschamps C, Trastek VF, Daly RC, Pairolero PC (1994) Results of surgical resection in patients with N 2 non-small cell lung cancer. Ann Thorac Surg. 57 (5): 1095–1100
Mountain CF (1994) Surgery for stage IIIa-N 2 non-small cell lung cancer. Cancer 73 (10): 2589–2598
Rush VW, Albain KS, Crowley JJ, Rice TW, Lonchyna V, McKenna R, Livingston RB. Griffin BR, Benfield JR (1993) Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. J Thorac Cardiovasc Surg 105 (1): 97–106
Schirren J, Cuenoud PF, Bülzebruck H, Krysa S, Brandscheid D, Müller KM, Vogt-Moykopf I (1993) N 2-surgery in bronchial carcinoma: Indications, technique and results. General Thoracic Surgery 1 (1): 32–41
Wannenmacher M (1988) Indikationen und Resultate der Strahlentherapie des Bronchialkarzinoms. Prax Klin Pneumol. 42: 352–356
Watanabe Y, Shimizu J, Oda M, Hayashi Y, Tatsuzawa Y, Watanabe S, Yoshida M, Iwa T (1991) Improved survival in left non-small cell lung cancer after more extensive operative procedure. Thorac Cardiovasc Surg 39 (2): 89–94
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Drings, P. et al. (1995). Multimodale Therapieansätze bei der chirurgischen Therapie des Bronchialkarzinoms im Stadium III. In: Hartel, W. (eds) Qualitätssicherung durch Zusammenarbeit in der Chirurgie. Langenbecks Archiv für Chirurgie, vol 1995. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85235-0_37
Download citation
DOI: https://doi.org/10.1007/978-3-642-85235-0_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60425-9
Online ISBN: 978-3-642-85235-0
eBook Packages: Springer Book Archive